The Digene® HPV Test is the only such test approved by the FDA that uses advanced molecular technology to detect the DNA (genetic material) of 13 high-risk types of HPV (the virus shown to actually cause virtually all cases of cervical cancer.)
Approved by the FDA in 2003 for cervical cancer screening in conjunction with a Pap, in women age 30 and older – Digene® HPV Test – is based on proprietary “Hybrid Capture” technology, which combines two innovations from the rapidly evolving field of life sciences – DNA/RNA probes and monoclonal antibodies – to allow rapid, standardized gene testing …read more

Rain clouds seem to have made my part of the world its indefinite home. The skies over us haven’t been clear for a week now and looks like will stay that way for several more days that hopefully won’t make it to Christmas-time like it did last year.
The words low pressure area, monsoon rains sound like the new mantra of the daily weather bulletin.
For someone like me relying on wireless internet and satellite TV, non-stop heavy rains are not good, hugely affecting all the signal that I need. And then the electricity went out for a whole eight hours …read more

The traditional Pap smear is still the best initial cervical cancer screening tool for younger women.
A new large Danish study however, found that a test for human papillomavirus (HPV) is a much more effective way of screening for potential cancer in older women (age 40 and above).
The researchers specifically found that the absolute risk of developing cervical cancer in an older woman who tests positive for HPV is greater than 20 percent within a 10-year period. They also note that most women who test positive for HPV also test negative on a Pap smear given at the same time.
As reported …read more